U.S. Markets closed

Cytokinetics, Incorporated (CYTK)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.45+0.20 (+1.40%)
At close: 4:00PM EDT

14.40 -0.05 (-0.32%)
After hours: 4:11PM EDT

People also watch
CORTGTXIARRYCRISCYCC
Full screen
Previous Close14.25
Open14.35
Bid14.35 x 100
Ask14.50 x 100
Day's Range14.20 - 14.65
52 Week Range8.06 - 17.20
Volume487,023
Avg. Volume752,778
Market Cap703.39M
Beta2.00
PE Ratio (TTM)195.27
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Cytokinetics, Inc. breached its 50 day moving average in a Bullish Manner : CYTK-US : June 15, 2017
    Capital Cube7 days ago

    Cytokinetics, Inc. breached its 50 day moving average in a Bullish Manner : CYTK-US : June 15, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Cytokinetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Capital Cube10 days ago

    ETFs with exposure to Cytokinetics, Inc. : June 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytokinetics, Inc. Here are 5 ETFs with the largest exposure to CYTK-US. Comparing the performance and risk of Cytokinetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cytokinetics, Inc. :CYTK-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017
    Capital Cube13 days ago

    Cytokinetics, Inc. :CYTK-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017

    Categories: Yahoo FinanceGet free summary analysis Cytokinetics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Cytokinetics, Inc. – Ligand Pharmaceuticals Incorporated, Trevena, Inc., Acorda Therapeutics, Inc., Amgen Inc., ArQule, Inc. and Array BioPharma Inc. (LGND-US, TRVN-US, ACOR-US, AMGN-US, ARQL-US and ARRY-US) that have also ... Read more (Read more...)